AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2023
Jun 2, 2023
32538_dirs_2023-06-02_a802d2dc-8f78-4969-bde2-4c0e2a14fdbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2023-06-01
Reporting Person: Ramasastry Saira (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-01 | Common Stock | S | 3500 | $25.67 | Disposed | 10619 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023.
More from Vir Biotechnology, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26